Cardiol Therapeutics reports topline results from phase II ARCHER trial of CardiolRx in acute myocarditis patients: Toronto, Ontario Friday, August 8, 2025, 12:00 Hrs [IST] Cardio ...

The vaccine used in this trial, known as AHEAD-MERIT (BNT113-01), will help the immune system recognise and kill cancer cells ...

Patients in England with head and neck cancer will be fast-tracked onto a clinical trial for a "potentially transformative" ...

Dorset patients with advanced head and neck cancer to join NHS England mRNA vaccine trial via Cancer Vaccine Launch Pad, ...

Relay Therapeutics beat analyst estimates for both GAAP revenue and earnings per share in Q2 2025. The company reported continued clinical advancement of its lead asset RLY-2608, with new positive ...

Most Americans get more than half their calories from ultra-processed foods, according to a new federal report.

Patients in England with head and neck cancer will be fast-tracked onto a clinical trial for a "potentially transformative" ...

People with head and neck cancer in England will be fast-tracked on to a clinical trial for a “potentially transformative” ...

NIH documents viewed by KFF Health News show a pronounced decline in patients at the 200-bed NIH hospital from February through April ...

Hundreds of peer-reviewed studies on marijuana and its components have been published in the first seven months of 2025, ...

The number of cancer clinical trial participants at the hospital as of July was down about 20% from last year, one NIH cancer ...